Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-23-000166

Chief Financial Officer gave up 2,569 shares (to pay taxes)

  • Chief Financial Officer acquired 6,297 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Tsuchimoto Kim R · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-31 Exercise or conversion : show line 1 in the form +5,067 19,846 D
2022-12-31 Shares withheld for taxes : show line 2 in the form −2,067 $2.37 $4,899 17,779 D
2023-01-01 Exercise or conversion : show line 3 in the form +1,230 19,009 D
2023-01-01 Shares withheld for taxes : show line 4 in the form −502 $2.37 $1,190 18,507 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-12-31 Exercise or conversion : show line 5 in the form Restricted Stock Units −5,067 55,917 D
2023-01-01 Exercise or conversion : show line 6 in the form Restricted Stock Units −1,230 1,231 D
Loading xslF345X03/rdgdoc.xml…